4 Chronic Myeloid Leukemia Clinical Trials in Birmingham, AL (2026)

Q: How do I join a clinical trial in Birmingham?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you.

Recruiting Chronic Myeloid Leukemia Studies in Birmingham

NCT07091019Recruiting

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

This CML disease registry (ASC4REAL-2) aims to gather evidence on the tolerability, safety, effectiveness, and patient-reported outcomes (PRO) in real-world healthcare from patients with Ph+-CML-CP tr...

Birmingham, AL1,000 participantsNovartis Pharmaceuticals

View Study Details

NCT06423911Recruiting

Study of Olverembatinib (HQP1351) in Patients With CP-CML

A Global Multicenter, Open Label, Randomized, Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients with Chronic Phase Chronic Myeloid Leukemia (POLARIS-2)...

Birmingham, ALPHASE3333 participantsAscentage Pharma Group Inc.

View Study Details

NCT06163430Recruiting

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

The goal of the study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of TERN-701, a highly selective allosteric inhibitor of BCR-ABL1, in participants with pr...

Birmingham, ALPHASE1180 participantsTerns, Inc.

View Study Details

NCT03739814Recruiting

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

This phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage acute lymphoblastic leukemia that is newly ...

Birmingham, ALPHASE284 participantsNational Cancer Institute (NCI)

View Study Details

About Chronic Myeloid Leukemia Clinical Trials in Birmingham

Chronic myeloid leukemia (CML) is a type of cancer that starts in blood-forming cells of the bone marrow, characterized by the Philadelphia chromosome and BCR-ABL fusion gene. It was one of the first cancers treated successfully with targeted therapy. Tyrosine kinase inhibitors like imatinib have transformed CML into a manageable chronic condition.

There are currently 4 chronic myeloid leukemia clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 1,597 participants. Research is being sponsored by Novartis Pharmaceuticals, Ascentage Pharma Group Inc., Terns, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Myeloid Leukemia Clinical Trials in Birmingham — FAQ

Are there chronic myeloid leukemia clinical trials in Birmingham?

Yes, there are 4 chronic myeloid leukemia clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What chronic myeloid leukemia treatments are being tested?

The 4 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for chronic myeloid leukemia.

Data updated October 15, 2026 from ClinicalTrials.gov